These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

996 related articles for article (PubMed ID: 32517663)

  • 61. Repeat LEEP conization in patients with cervical intraepithelial neoplasia grade 3 and positive ectocervical margins.
    Ayhan A; Boynukalin FK; Guven S; Dogan NU; Esinler I; Usubutun A
    Int J Gynaecol Obstet; 2009 Apr; 105(1):14-7. PubMed ID: 19111301
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment.
    Hildesheim A; Gonzalez P; Kreimer AR; Wacholder S; Schussler J; Rodriguez AC; Porras C; Schiffman M; Sidawy M; Schiller JT; Lowy DR; Herrero R;
    Am J Obstet Gynecol; 2016 Aug; 215(2):212.e1-212.e15. PubMed ID: 26892991
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Estimation of the potential overall impact of human papillomavirus vaccination on cervical cancer cases and deaths.
    Van Kriekinge G; Castellsagué X; Cibula D; Demarteau N
    Vaccine; 2014 Feb; 32(6):733-9. PubMed ID: 24291200
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Persistence of human papillomavirus as a predictor for treatment failure after loop electrosurgical excision procedure.
    Bae JH; Kim CJ; Park TC; Namkoong SE; Park JS
    Int J Gynecol Cancer; 2007; 17(6):1271-7. PubMed ID: 17442018
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prediction of recurrent disease by cytology and HPV testing after treatment of cervical intraepithelial neoplasia.
    Aerssens A; Claeys P; Beerens E; Garcia A; Weyers S; Van Renterghem L; Praet M; Temmerman M; Velasquez R; Cuvelier CA
    Cytopathology; 2009 Feb; 20(1):27-35. PubMed ID: 18510550
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS report.
    Castle PE; Stoler MH; Solomon D; Schiffman M
    Am J Clin Pathol; 2007 May; 127(5):805-15. PubMed ID: 17439841
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.
    Lehtinen M; Paavonen J; Wheeler CM; Jaisamrarn U; Garland SM; Castellsagué X; Skinner SR; Apter D; Naud P; Salmerón J; Chow SN; Kitchener H; Teixeira JC; Hedrick J; Limson G; Szarewski A; Romanowski B; Aoki FY; Schwarz TF; Poppe WA; De Carvalho NS; Germar MJ; Peters K; Mindel A; De Sutter P; Bosch FX; David MP; Descamps D; Struyf F; Dubin G;
    Lancet Oncol; 2012 Jan; 13(1):89-99. PubMed ID: 22075171
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Gene expression profiling informs HPV cervical histopathology but not recurrence/relapse after LEEP in ART-suppressed HIV+HPV+ women.
    Papasavvas E; Kossenkov AV; Azzoni L; Zetola NM; Mackiewicz A; Ross BN; Fair M; Vadrevu S; Ramogola-Masire D; Sanne I; Firnhaber C; Montaner LJ
    Carcinogenesis; 2019 Apr; 40(2):225-233. PubMed ID: 30364933
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Management of high-grade squamous intraepithelial lesion patients with positive margin after LEEP conization: A retrospective study.
    Abdulaziz AMA; You X; Liu L; Sun Y; Zhang J; Sun S; Li X; Sun W; Dong Y; Liu H; Zhang Y
    Medicine (Baltimore); 2021 May; 100(20):e26030. PubMed ID: 34011112
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The residual rate of HPV and the recurrence rate of CIN after LEEP with negative margins: A meta-analysis.
    Lin Y; Long Y; He J; Yi Q
    PLoS One; 2024; 19(3):e0298520. PubMed ID: 38484015
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Correlation of recurrence rates and times with posttreatment human papillomavirus status in patients treated with loop electrosurgical excision procedure conization for cervical squamous intraepithelial lesions.
    Prato B; Ghelardi A; Gadducci A; Marchetti I; Di Cristofano C; Di Coscio G; Bevilacqua G; Genazzani AR
    Int J Gynecol Cancer; 2008; 18(1):90-4. PubMed ID: 17506849
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Impact of HPV-16/18 AS04-adjuvanted vaccine on preventing subsequent infection and disease after excision treatment: post-hoc analysis from a randomized controlled trial.
    Zhao S; Hu S; Xu X; Zhang X; Pan Q; Chen F; Zhao F
    BMC Infect Dis; 2020 Nov; 20(1):846. PubMed ID: 33198657
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cervical intraepithelial neoplasia grade 3 in a patient following Gardasil vaccination.
    McLucas B; Vail E; Chua KJ; Walt G
    BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31401577
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Low-grade squamous intraepithelial lesion/cannot exclude high-grade squamous intraepithelial lesion (LSIL-H) is a unique category of cytologic abnormality associated with distinctive HPV and histopathologic CIN 2+ detection rates.
    Barron S; Li Z; Austin RM; Zhao C
    Am J Clin Pathol; 2014 Feb; 141(2):239-46. PubMed ID: 24436272
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Human papillomavirus types in cervical dysplasia among young HPV-vaccinated women: Population-based nested case-control study.
    Kann H; Hortlund M; Eklund C; Dillner J; Faust H
    Int J Cancer; 2020 May; 146(9):2539-2546. PubMed ID: 31868230
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Expression of p16 and HPV E4 on biopsy samples and methylation of FAM19A4 and miR124-2 on cervical cytology samples in the classification of cervical squamous intraepithelial lesions.
    Leeman A; Jenkins D; Del Pino M; Ordi J; Torné A; Doorbar J; Meijer CJLM; van Kemenade FJ; Quint WGV
    Cancer Med; 2020 Apr; 9(7):2454-2461. PubMed ID: 32022461
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparison of 5-ALA-PDT and LEEP of cervical squamous intraepithelial neoplasia (CIN2) with high-risk human papillomavirus infection in childbearing age women: A non-randomized controlled polit study.
    Wang L; Liu X; Zhang J; Song M; Liu H; Xu Y; Meng L; Zhang Y; Jia L
    Photodiagnosis Photodyn Ther; 2024 Apr; 46():104044. PubMed ID: 38467338
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The efficacy and safety of Tipapkinogen Sovacivec therapeutic HPV vaccine in cervical intraepithelial neoplasia grades 2 and 3: Randomized controlled phase II trial with 2.5 years of follow-up.
    Harper DM; Nieminen P; Donders G; Einstein MH; Garcia F; Huh WK; Stoler MH; Glavini K; Attley G; Limacher JM; Bastien B; Calleja E
    Gynecol Oncol; 2019 Jun; 153(3):521-529. PubMed ID: 30955915
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Loop Electrosurgical Excision Procedure Treats Cervical Intraepithelial Neoplasia 2/3 Among HIV- and HIV+ Women in Kenya.
    Orang'o O; Mehta N; Itsura P; Tonui P; Bussmann H; Bogers JP; Liu T; Cu-Uvin S
    J Low Genit Tract Dis; 2020 Jan; 24(1):21-26. PubMed ID: 31860571
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Loop electrosurgical excision procedure followed by 5-aminolevulinic acid photodynamic therapy for cervical intraepithelial neoplasia, a report of six cases.
    Cai H; Ma T; Che Y; Wang Y; Wang C; Yin G
    Photodiagnosis Photodyn Ther; 2020 Mar; 29():101650. PubMed ID: 31923634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.